Accelerate Historical Balance Sheet

AXDX Stock

USD 0.75 0.11 12.79%

Trend analysis of Accelerate Diagnostics balance sheet accounts such as Other Current Liab of 8.6 M, Total Current Liabilities of 32.8 M or Property Plant And Equipment Net of 6.1 M provides information on Accelerate Diagnostics' total assets, liabilities, and equity, which is the actual value of Accelerate Diagnostics to its prevalent stockholders. By breaking down trends over time using Accelerate Diagnostics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Accelerate Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Accelerate Diagnostics is a good buy for the upcoming year.

Accelerate Diagnostics Inventory

2.73 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Accelerate Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Accelerate Stock please use our How to Invest in Accelerate Diagnostics guide.

About Accelerate Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Accelerate Diagnostics at a specified time, usually calculated after every quarter, six months, or one year. Accelerate Diagnostics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Accelerate Diagnostics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Accelerate currently owns. An asset can also be divided into two categories, current and non-current.

Accelerate Diagnostics Balance Sheet Chart

At this time, Accelerate Diagnostics' Liabilities And Stockholders Equity is fairly stable compared to the past year. Non Current Liabilities Total is likely to rise to about 56.1 M in 2025, despite the fact that Total Stockholder Equity is likely to grow to (53.2 M).

Total Assets Other Current Liab Total Current Liabilities Property Plant And Equipment Net

Add Fundamental

Total Assets

Total assets refers to the total amount of Accelerate Diagnostics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Accelerate Diagnostics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Accelerate Diagnostics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Accelerate Diagnostics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Most accounts from Accelerate Diagnostics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Accelerate Diagnostics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Accelerate Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Accelerate Stock please use our How to Invest in Accelerate Diagnostics guide.At this time, Accelerate Diagnostics' Liabilities And Stockholders Equity is fairly stable compared to the past year. Non Current Liabilities Total is likely to rise to about 56.1 M in 2025, despite the fact that Total Stockholder Equity is likely to grow to (53.2 M).

	2022	2023	2024	2025 (projected)
Other Current Liabilities	3.2M	3.4M	8.2M	8.6M
Total Assets	65.0M	31.4M	28.6M	47.6M

Other Current Liab Total Assets

Accelerate Diagnostics balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock Total Equity	Common Stock	Current Deferred Revenue	Other Liab	Other Assets	Treasury Stock
Total Assets		0.33	-0.07	0.47	0.64	0.02	-0.09	0.03	0.77	0.52	0.05	0.98	0.24	-0.12	0.47	-0.13	0.17	0.42	0.11	1.0	-0.54	-0.53	-0.2	-0.7	0.07	-0.24
Other Current Liab	0.33		0.48	-0.36	0.64	0.51	-0.78	0.69	0.11	0.5	-0.25	0.2	0.65	0.84	0.53	0.44	0.85	0.65	0.87	0.31	-0.48	-0.46	0.7	-0.04	-0.03	-0.68
Total Current Liabilities	-0.07	0.48		-0.41	0.39	0.32	-0.67	0.74	-0.05	0.33	-0.08	-0.16	0.5	0.52	0.06	0.4	0.67	0.35	0.51	-0.09	-0.3	-0.3	0.48	0.46	0.01	-0.53
Total Stockholder Equity	0.47	-0.36	-0.41		-0.3	-0.82	0.64	-0.34	0.49	-0.37	0.59	0.59	-0.53	-0.47	-0.51	-0.64	-0.5	-0.6	-0.54	0.51	-0.06	-0.05	-0.43	-0.33	-0.47	0.68
Property Plant And Equipment Net	0.64	0.64	0.39	-0.3		0.62	-0.71	0.49	0.42	0.93	-0.3	0.51	0.75	0.32	0.81	0.48	0.7	0.88	0.66	0.59	-0.64	-0.64	0.24	-0.36	0.4	-0.81
Net Debt	0.02	0.51	0.32	-0.82	0.62		-0.68	0.23	-0.32	0.69	-0.71	-0.12	0.73	0.33	0.82	0.59	0.56	0.86	0.55	-0.02	-0.16	-0.16	0.33	-0.16	0.58	-0.84
Retained Earnings	-0.09	-0.78	-0.67	0.64	-0.71	-0.68		-0.84	0.06	-0.67	0.3	0.07	-0.82	-0.77	-0.57	-0.84	-0.98	-0.73	-0.92	-0.05	0.52	0.52	-0.76	-0.22	-0.21	0.89
Accounts Payable	0.03	0.69	0.74	-0.34	0.49	0.23	-0.84		0.1	0.37	0.07	-0.09	0.61	0.82	0.15	0.69	0.89	0.36	0.87	0.01	-0.55	-0.54	0.8	0.45	-0.16	-0.61
Cash	0.77	0.11	-0.05	0.49	0.42	-0.32	0.06	0.1		0.29	0.28	0.79	-0.04	-0.13	0.22	-0.2	0.03	0.19	0.02	0.78	-0.43	-0.41	-0.3	-0.34	-0.03	-0.06
Non Current Assets Total	0.52	0.5	0.33	-0.37	0.93	0.69	-0.67	0.37	0.29		-0.44	0.4	0.78	0.18	0.82	0.51	0.61	0.86	0.56	0.47	-0.39	-0.43	0.17	-0.32	0.47	-0.79
Non Currrent Assets Other	0.05	-0.25	-0.08	0.59	-0.3	-0.71	0.3	0.07	0.28	-0.44		0.14	-0.39	-0.06	-0.58	-0.33	-0.18	-0.57	-0.21	0.08	-0.23	-0.25	-0.17	0.26	-0.73	0.45
Cash And Short Term Investments	0.98	0.2	-0.16	0.59	0.51	-0.12	0.07	-0.09	0.79	0.4	0.14		0.08	-0.24	0.36	-0.27	0.02	0.28	-0.04	0.99	-0.48	-0.46	-0.32	-0.71	0.01	-0.09
Net Receivables	0.24	0.65	0.5	-0.53	0.75	0.73	-0.82	0.61	-0.04	0.78	-0.39	0.08		0.46	0.65	0.67	0.77	0.76	0.74	0.19	-0.32	-0.31	0.59	-0.13	0.16	-0.86
Common Stock Shares Outstanding	-0.12	0.84	0.52	-0.47	0.32	0.33	-0.77	0.82	-0.13	0.18	-0.06	-0.24	0.46		0.21	0.56	0.83	0.35	0.88	-0.14	-0.4	-0.4	0.87	0.4	-0.17	-0.51
Non Current Liabilities Total	0.47	0.53	0.06	-0.51	0.81	0.82	-0.57	0.15	0.22	0.82	-0.58	0.36	0.65	0.21		0.45	0.49	0.95	0.51	0.43	-0.35	-0.35	0.11	-0.47	0.59	-0.81
Other Current Assets	-0.13	0.44	0.4	-0.64	0.48	0.59	-0.84	0.69	-0.2	0.51	-0.33	-0.27	0.67	0.56	0.45		0.77	0.54	0.78	-0.17	-0.38	-0.37	0.69	0.31	0.31	-0.76
Other Stockholder Equity	0.17	0.85	0.67	-0.5	0.7	0.56	-0.98	0.89	0.03	0.61	-0.18	0.02	0.77	0.83	0.49	0.77		0.65	0.94	0.14	-0.6	-0.6	0.8	0.21	0.09	-0.82
Total Liab	0.42	0.65	0.35	-0.6	0.88	0.86	-0.73	0.36	0.19	0.86	-0.57	0.28	0.76	0.35	0.95	0.54	0.65		0.64	0.38	-0.42	-0.42	0.25	-0.3	0.56	-0.92
Property Plant And Equipment Gross	0.11	0.87	0.51	-0.54	0.66	0.55	-0.92	0.87	0.02	0.56	-0.21	-0.04	0.74	0.88	0.51	0.78	0.94	0.64		0.08	-0.53	-0.53	0.82	0.2	0.04	-0.79
Total Current Assets	1.0	0.31	-0.09	0.51	0.59	-0.02	-0.05	0.01	0.78	0.47	0.08	0.99	0.19	-0.14	0.43	-0.17	0.14	0.38	0.08		-0.53	-0.51	-0.22	-0.7	0.04	-0.2
Common Stock Total Equity	-0.54	-0.48	-0.3	-0.06	-0.64	-0.16	0.52	-0.55	-0.43	-0.39	-0.23	-0.48	-0.32	-0.4	-0.35	-0.38	-0.6	-0.42	-0.53	-0.53		0.97	-0.33	0.21	-0.14	0.44
Common Stock	-0.53	-0.46	-0.3	-0.05	-0.64	-0.16	0.52	-0.54	-0.41	-0.43	-0.25	-0.46	-0.31	-0.4	-0.35	-0.37	-0.6	-0.42	-0.53	-0.51	0.97		-0.31	0.17	-0.12	0.44
Current Deferred Revenue	-0.2	0.7	0.48	-0.43	0.24	0.33	-0.76	0.8	-0.3	0.17	-0.17	-0.32	0.59	0.87	0.11	0.69	0.8	0.25	0.82	-0.22	-0.33	-0.31		0.33	-0.12	-0.48
Other Liab	-0.7	-0.04	0.46	-0.33	-0.36	-0.16	-0.22	0.45	-0.34	-0.32	0.26	-0.71	-0.13	0.4	-0.47	0.31	0.21	-0.3	0.2	-0.7	0.21	0.17	0.33		-0.29	0.02
Other Assets	0.07	-0.03	0.01	-0.47	0.4	0.58	-0.21	-0.16	-0.03	0.47	-0.73	0.01	0.16	-0.17	0.59	0.31	0.09	0.56	0.04	0.04	-0.14	-0.12	-0.12	-0.29		-0.38
Treasury Stock	-0.24	-0.68	-0.53	0.68	-0.81	-0.84	0.89	-0.61	-0.06	-0.79	0.45	-0.09	-0.86	-0.51	-0.81	-0.76	-0.82	-0.92	-0.79	-0.2	0.44	0.44	-0.48	0.02	-0.38

Click cells to compare fundamentals

Accelerate Diagnostics Account Relationship Matchups

Accelerate Diagnostics balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	93.4M	83.0M	65.0M	31.4M	28.6M	47.6M
Other Current Liab	3.8M	3.1M	3.2M	3.4M	8.2M	8.6M
Total Current Liabilities	7.0M	6.9M	66.6M	12.0M	31.2M	32.8M
Total Stockholder Equity	(62.8M)	(35.1M)	(22.3M)	(19.9M)	(56.0M)	(53.2M)
Property Plant And Equipment Net	9.3M	7.9M	7.8M	5.1M	5.8M	6.1M
Net Debt	114.2M	71.2M	42.6M	27.1M	48.3M	50.7M
Retained Earnings	(493.0M)	(570.7M)	(607.2M)	(668.9M)	(718.9M)	(683.0M)
Accounts Payable	1.3M	2.0M	4.5M	4.8M	4.8M	5.1M
Cash	35.8M	39.9M	34.9M	12.1M	15.1M	23.5M
Non Current Assets Total	11.4M	9.7M	9.0M	6.9M	6.3M	5.4M
Non Currrent Assets Other	(5.9M)	1.8M	1.2M	1.8M	500K	683.3K
Cash And Short Term Investments	68.3M	63.6M	45.6M	13.2M	15.1M	14.3M
Net Receivables	1.6M	2.3M	2.4M	2.6M	2.0M	2.1M
Common Stock Shares Outstanding	5.5M	5.6M	6.2M	12.5M	23.3M	24.5M
Liabilities And Stockholders Equity	93.4M	83.0M	65.0M	31.4M	28.6M	47.6M
Non Current Liabilities Total	149.3M	111.2M	20.7M	39.2M	53.4M	56.1M
Other Current Assets	3.0M	2.3M	2.0M	5.3M	2.3M	2.4M
Other Stockholder Equity	430.0M	535.6M	585.3M	649.6M	747.0M	784.4M
Total Liab	156.2M	118.1M	87.3M	51.3M	84.6M	88.8M
Property Plant And Equipment Gross	9.3M	7.9M	7.8M	16.1M	17.2M	18.1M
Total Current Assets	82.0M	73.3M	56.0M	24.5M	22.2M	42.2M
Accumulated Other Comprehensive Income	91K	(60K)	(400K)	(612K)	(550.8K)	(523.3K)
Common Stock	58K	68K	97K	14K	12.6K	12.0K
Current Deferred Revenue	376K	451K	547K	1.5M	1.6M	1.7M
Other Liab	19K	335K	808K	1.5M	1.4M	1.5M
Other Assets	5.3M	1.8M	1.2M	1.0	1.15	1.09
Property Plant Equipment	7.9M	6.1M	7.9M	7.8M	8.9M	9.4M
Inventory	9.2M	5.1M	5.2M	3.3M	2.9M	2.7M
Short Term Debt	1.5M	1.4M	58.4M	2.3M	16.5M	9.9M
Net Tangible Assets	(7.4M)	(62.8M)	(35.1M)	(22.3M)	(20.0M)	(19.0M)
Long Term Debt	145.9M	108.0M	16.9M	36.1M	46.8M	51.1M
Retained Earnings Total Equity	(330.3M)	(414.7M)	(493.0M)	(570.7M)	(513.6M)	(487.9M)
Short Term Investments	32.5M	23.7M	10.7M	1.1M	1.2M	1.1M
Capital Surpluse	432.9M	452.3M	475.1M	580.7M	667.7M	701.1M
Non Current Liabilities Other	3.4M	3.2M	874K	1.2M	1.7M	1.6M
Short Long Term Debt Total	150.0M	111.1M	77.5M	39.2M	63.4M	85.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Accelerate Stock Analysis

When running Accelerate Diagnostics' price analysis, check to measure Accelerate Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accelerate Diagnostics is operating at the current time. Most of Accelerate Diagnostics' value examination focuses on studying past and present price action to predict the probability of Accelerate Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accelerate Diagnostics' price. Additionally, you may evaluate how the addition of Accelerate Diagnostics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Accelerate Historical Balance Sheet

Accelerate Diagnostics Inventory

2.73 Million

About Accelerate Balance Sheet Analysis

Accelerate Diagnostics Balance Sheet Chart

Total Assets

Total Current Liabilities

Property Plant And Equipment Net

Accelerate Diagnostics balance sheet Correlations

Accelerate Diagnostics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Accelerate Diagnostics balance sheet Accounts

Also Currently Popular

Additional Tools for Accelerate Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 0.99	Cash And Short Term Investments
Cash And Short Term Investments	+ 0.98	Total Assets
Common Stock	+ 0.97	Common Stock Total Equity
Total Liab	+ 0.95	Non Current Liabilities Total
Property Plant And Equipment Gross	+ 0.94	Other Stockholder Equity

Other Stockholder Equity	- 0.98	Retained Earnings
Treasury Stock	- 0.92	Total Liab
Property Plant And Equipment Gross	- 0.92	Retained Earnings
Treasury Stock	- 0.86	Net Receivables
Other Current Assets	- 0.84	Retained Earnings
Accounts Payable	- 0.84	Retained Earnings